INTARCIA THERAPEUTICS, INC
Profile
Company Names
INTARCIA THERAPEUTICS, INC
Addresses
ONE MARINA PARK DRIVE, 13TH FLOOR, BOSTON, MA 02110
1 MARINA PARK DRIVE, 13TH FLOOR, BOSTON, MA 02210
155 SEAPORT BOULEVARD, 11TH FLOOR, BOSTON, MA 02210
24650 INDUSTRIAL BLVD., HAYWARD, CA 94545
Phone Numbers
(617) 936-2500
617-936-2500
(510) 782-7880
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$1,007,528,008.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2019-02-26
$198,498,007.00
$280,000,000.00
$81,501,993.00
Debt
8
2016-12-31
$3,594.00
$3,594.00
$0.00
Equity
7
2016-09-02
$524,601,480.00
$850,000,020.00
$325,398,540.00
Equity
6
2014-03-27
$200,000,023.00
$200,000,023.00
$0.00
Equity
5
2012-11-14
$7,868,967.00
$7,868,967.00
$0.00
Equity
4
2012-08-07
$7,250,000.00
$7,250,000.00
$0.00
Debt
3
2010-08-25
$45,791,354.00
$47,523,114.00
$1,731,760.00
Debt
2
2010-03-19
$14,488,394.00
$16,000,000.00
$1,511,606.00
Equity, Debt
1
2009-11-16
$9,026,189.00
$9,026,189.00
$0.00
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICK
CONWAY
DIRECTOR
DAVID
FRANKLIN
EXECUTIVE OFFICER
KURT
GRAVES
DIRECTOR, EXECUTIVE OFFICER
ED
MATHERS
DIRECTOR
LIQUIDIA TECHNOLOGIES INC
| INTARCIA THERAPEUTICS, INC
| ENVISIA THERAPEUTICS INC.
| SYNLOGIC, INC.
| MIRNA THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| ENVISIA THERAPEUTICS, INC.
| SYNLOGIC, LLC
| TREVI THERAPEUTICS, INC.
| AKOUOS, INC.
| RENEO PHARMACEUTICALS, INC.
| SENTI BIOSCIENCES, INC.
| MIRUM PHARMACEUTICALS, INC.
| CURZION PHARMACEUTICALS, INC.
JAMES
NIEDEL
DIRECTOR
BRYAN
ROBERTS
DIRECTOR
VITAE PHARMACEUTICALS, INC
| VENTANA HEALTH SERVICES, INC.
| INTARCIA THERAPEUTICS, INC
| CASTLIGHT HEALTH, INC.
| TANDEM TECHNOLOGIES, INC.
| SURFACE LOGIX INC
| POWERVISION, INC.
| CODERYTE INC
| KYRUUS, INC.
| ARIA DIAGNOSTICS, INC.
| ACHAOGEN INC
| FATE THERAPEUTICS INC
| ADVANCE MEDICAL, LTD.
| BELLEROPHON THERAPEUTICS LLC
| MUSE BIOTECHNOLOGY, INC.
| STRIDE HEALTH, INC.
| DEVOTED HEALTH, INC.
| INSCRIPTA, INC.
| LYRA HEALTH, INC.
| PSY THERAPEUTICS, INC.
| MYTHIC THERAPEUTICS, INC.
| SITKA, INC./DELAWARE
| PUBLIC HEALTH CO GROUP, INC.
| GRAND ROUNDS, INC.
| SMITH HEALTH, INC.
| KELONIA THERAPEUTICS, INC.
| JW CELTICS INVESTMENT CORP.
| ACCOMPANY HEALTH, INC.
GINO
SANTINI
DIRECTOR
GLEN
SATO
DIRECTOR
JAY
SMITH
EXECUTIVE OFFICER
MICHAEL
WILLIAMS
EXECUTIVE OFFICER
FULL METAL MINERALS LTD
| UNDERWORLD RESOURCES INC
| CUREX GROUP HOLDINGS, LLC
| MERKLE GROUP INC
| WESTERN PACIFIC RESOURCES CORP
| ENTOURAGE METALS LTD.
| REVOLUTION RESOURCES CORP.
| SUNSHINE SILVER MINES CORP
| MEDIA TECHNOLOGIES, INC.
| SOCIALWARE, INC.
| FULL METAL ZINC LTD.
| OOMBA, INC.
| DIGIFIT, INC.
| ELECTRUM GLOBAL HOLDINGS L.P.
| ELECTRUM US HOLDINGS I L.P.
| CCPI INC.
| GUARDIAN PHALANX OFFSHORE FUND, LTD.
| GUARDIAN MULTI-STRATEGY FUND, LP
| NAPIER PARK SELECT FUND LP
| XZERES CORP.
| NAPIER PARK ABS INCOME FUND LP
| NAPIER PARK STRATEGIC CLO FUND LP
| INTARCIA THERAPEUTICS, INC
| PRACTICA, L.L.C
| ARCLIGHT FUND MANAGEMENT, LLC
| FREMONT GOLD LTD.
| SCOUT MILITARY DISCOUNTS, LLC
| NAPIER PARK CREDIT STRATEGIES BPI LP
| NAPIER PARK ABS INCOME FUND (CAYMAN) LP
| MINAURUM GOLD INC.
| OC 537 OFFSHORE ERISA FUND, LTD.
| NAPIER PARK-TX OPPORTUNISTIC CREDIT FUND LP
| OC 537 OFFSHORE FUND, LTD.
| VENDETTA MINING CORP.
| TUCKY LENDING, LP
| AMERICAN AEROGEL CORP
| NAPIER PARK DEEP VALUE CREDIT FUND LP
| NAPIER PARK DEEP VALUE CREDIT FUND (CAYMAN) LP
| AFTERMATH SILVER LTD.
| NAPIER PARK AIR ROLLOVER PROJECT ENTITY LP
| NAPIER PARK RAIL III PROJECT ENTITY LP
| NP RAILCAR INVESTMENTS III LP
| MAVERICK TOPCO, LLC
| NAPIER PARK DIVERSIFIED ASSETS PROJECT ENTITY I LP
| NAPIER PARK IAA PROJECT ENTITY LP
| NAPIER PARK DEEP VALUE CREDIT FUND II LP
| NAPIER PARK DEEP VALUE CREDIT FUND (CAYMAN) II LP
| NAPIER PARK EUROPE SPC - CHELTENHAM SP
| MATTERHORN TOPCO, L.P.
| NAPIER PARK ETON FUND GLOBAL FEEDER LTD
| GREY POINTE, INC.
| GREEN ROCK INVESTORS, LLC/CA
| NAPIER PARK ETON FUND US FEEDER LLC
| HEIGHTS ON KATY, LLC
| TWP PECAN RIDGE, LLC
| ARRAY APARTMENTS LSP, LLC
| SUNBELT DIVERSIFIED PORTFOLIO, LLC
| NAPIER PARK INVESTMENTS II LP
| TPC SOLAR INVESTORS 2022, LLC
| OASIS INVESTMENT PARTNERS, LLC
| NAPIER PARK CENTRE STREET CLO PARTNERSHIP FUND LP
| SARCIO, INC.
| VORTEX METALS INC.
| SPEP MSP BUYER, LLC
| NAPIER PARK VALUE CREDIT FUND I LP
| NAPIER PARK VALUE CREDIT FUND (CAYMAN) I LP
| DATAXTRAX INC.
| NAPIER PARK CONCORDE US FEEDER LP
| CASH FLOW FUND 2 LLC
| ELECTRUM DISCOVERY CORP.
| ALPHAHEALTH INC
| AMERICAN FIRST CREDIT UNION
| STRIDE VENTURES UK INVESTMENTS L.P.
| NAPIER PARK EUROPE SPC - CONCORDE SP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2019-02-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2019-02-26
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-02
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-31
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-09-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-27
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-11-14
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-11-14
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2010-08-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2012-08-07
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2010-08-25
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2010-08-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2010-08-25
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2010-03-19
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2009-11-16
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2009-11-16
